Adolescents and young adults who are current smokers are strongly recommended to receive MenACWY and MenB vaccines
Adolescents and young adults (aged 15–24 years) who are current smokers are strongly recommended to receive:
- 1 dose of MenACWY vaccine
- 2 doses of MenB vaccine
For MenACWY vaccine, it is preferable for adolescents and young adults to receive either Menveo or Nimenrix, rather than Menactra. If Menveo and Nimenrix are unavailable, Menactra can be given.
There is no preference for either brand of MenB vaccine — Bexsero or Trumenba — for adolescents and young adults.
Bexsero and Trumenba are not interchangeable. The same vaccine should be used for both vaccine doses.
Smoking tobacco increases the risk of carrying meningococcal bacteria in the upper respiratory tract. It also increases the risk of transmitting the bacteria to close contacts. Smokers are at greater risk of meningococcal disease because they have higher meningococcal carriage rates than non-smokers.8-10
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/recommendations/adolescents-and-young-adults-who-are-current-smokers-are-strongly-recommended-to.